Volume 17, Number 7—July 2011
Plasmodium knowlesi Reinfection in Human
Highlight and copy the desired format.
|EID||Lau Y, Tan LH, Chin LC, Fong M, Noraishah MA, Rohela M, et al. Plasmodium knowlesi Reinfection in Human. Emerg Infect Dis. 2011;17(7):1314-1315. https://dx.doi.org/10.3201/eid1707.101295|
|AMA||Lau Y, Tan LH, Chin LC, et al. Plasmodium knowlesi Reinfection in Human. Emerging Infectious Diseases. 2011;17(7):1314-1315. doi:10.3201/eid1707.101295.|
|APA||Lau, Y., Tan, L. H., Chin, L. C., Fong, M., Noraishah, M. A., & Rohela, M. (2011). Plasmodium knowlesi Reinfection in Human. Emerging Infectious Diseases, 17(7), 1314-1315. https://dx.doi.org/10.3201/eid1707.101295.|
To the Editor: In 2004, a large number of patients infected with Plasmodium knowlesi (simian malarial species) were reported in Sarawak, Malaysia (1). P. knowlesi infection was also reported in Peninsular Malaysia (2).
Here we report a case of human P. knowlesi reinfection. Phylogenetic sequence analysis shows that the first and second infections were caused by different strains of P. knowlesi.
The patient was a 41-year-old businessman from Peninsular Malaysia. He was first admitted to the hospital in October 2009 with a 4-day history of fever, chills, and headache. His symptoms started ≈2 weeks after a 4-wheel-drive expedition with overnight camping in a jungle in Raub in the state of Pahang. Initial examination showed thrombocytopenia and hepatitis, and P. knowlesi malaria was subsequently confirmed with nested PCR by using diagnostic primers for Plasmodium small subunit (SSU) rRNA as described (3). He recovered fully after a treatment course of oral quinine plus doxycycline.
The patient was readmitted to the hospital on June 11, 2010, with a 5-day history of fever and chills and rigors, followed by epigastric pain, nausea, and vomiting. His symptoms began 15 days after another 4-wheel-drive expedition with overnight camping in a jungle in Tanjung Malim in the state of Perak. Laboratory investigations showed severe thrombocytopenia. Falciparum malaria was diagnosed initially on the basis of blood film examination with 1% parasitemia. The patient was administered oral mefloquine (750 mg) followed by 500 mg and 250 mg at 6 hours and 12 hours, respectively. His parasitemia level increased from 1.0% to 2.5% despite treatment with mefloquine. Oral quinine and doxycycline were initiated. However, renal function deteriorated further, and acute hemolysis was evident. Oral quinine was changed to intravenous quinine infusion, and oral combination of artemether and lumefantrine was added. Intermittent hemodialysis was initiated, and 1 unit each of packed erythrocyte cells and whole blood were transfused. Parasitemia eventually cleared on June 16, 2010. PCR confirmed P. knowlesi in the patient’s blood sample.
P. knowlesi has a 24-hour asexual life cycle, resulting in daily schizont rupture, which leads to high parasitemia levels. Delay in appropriate treatment, as seen in the second infection of the patient in our study, can cause severe conditions, such as thrombocytopenia, acute renal failure, and hemolysis (4).
To confirm the reinfection, blood samples collected from the patient at the first and second infections were reexamined. Giemsa-stained thin and thick blood films showed 2.0% and 2.5% parasitemia for the first and second infections, respectively. Some parasites showed morphologic features resembling those of P. falciparum ring forms and P. malariae trophozoite band forms.
We confirmed the P. knowlesi in the first and second infections by PCR, sequencing and analysis of the highly variable csp gene (5), and SSU rRNA. The nucleotide sequences of the gene were aligned by using ClustalW and analyzed by using MEGA4 software (6). The csp gene of the isolate from the first infection (denoted as Pkpah-1) was 1,217 nt, whereas the gene of the isolate from the second infection (denoted as Pkprk-1) contained 1,277 nt. This difference was due to the absence of 2 repetitive sequences (5′-gtggagcaaatgcaggacaaccgaatgcag-3′; 5′-agcaaatgcaggacaaccgaatgcagaagg-3′) in the csp gene of Pkpah-1. Furthermore, the alignment showed 21 variable sites between the genes. Phylogenetic analysis based on SSU rRNA sequences indicated that Pkpah-1 and Pkprk-1 formed a cluster, which was more related to P. knowlesi isolates from Thailand than to isolates from Sarawak, a Malaysian state in Borneo Island (Figure). Another isolate from Peninsular Malaysia, KAL-1, was also grouped with Pkpah-1 and Pkprk-1. The KAL-1 isolate was detected in a traveler from Finland returning from Peninsular Malaysia in 2007 (7).
P. knowlesi infection does not relapse because the parasite has no liver hypnozoite stage (8). Reinfection and recrudescence are not uncommon in malaria. The finding in the patient reported here indicates reinfection rather than recrudescence as confirmed by PCR genotyping. He acquired his infection while jungle trekking in Raub in October 2009 and was reinfected in Tanjung Malim in June 2010 (the great-circle distance between the 2 locations is 38.61 km). This case shows that immunity toward P. knowlesi infection is strain specific as has been observed in other malaria species (9). P. knowlesi is a nonhuman primate malaria species, and humans are accidental hosts when they go into areas where macaques dwell. P. knowlesi can cause reinfection and can potentially be severe in areas where it is endemic. Travelers to forested areas of endemicity should be advised to take strict antimosquito measures and prophylaxis. Physicians should be aware that P. knowlesi infection is a vital differential diagnosis in febrile travelers with a recent travel history to forested areas in Southeast Asia.
This study was supported by High Impact Research grant no. J-20011-73592 from the University of Malaya.
- Singh B, Lee KS, Matusop A, Radhakrishnan A, Shamsul SSG, Cox-Singh J, A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet. 2004;363:1017–24.
- Vythilingam I, Noorazian YM, Huat TC, Jiram AI, Yusri YM, Azahari AH, Plasmodium knowlesi in humans, macaques and mosquitoes in Peninsular Malaysia. Parasit Vectors. 2008;1:26.
- Singh B, Bobogare A, Cox-Singh J, Snounou G, Abdullah MS, Rahman HA. A genus- and species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies. Am J Trop Med Hyg. 1999;60:687–92.
- Daneshvar C, Davis C, Cox-Singh J, Rafa'ee M, Zakaria S, Divis P, Clinical and laboratory features of human Plasmodium falciparum infections. Clin Infect Dis. 2009;49:852–60.
- McCutchan TF, Kissinger JC, Touray MG, Rogers MJ, Li J, Sullivan M, Comparison of circumsporozoite proteins from avian and mammalian malarias: biological and phylogenetic implications. Proc Natl Acad Sci U S A. 1996;93:11889–94.
- Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007;24:1596–9.
- Kantele A, Marti H, Felger I, Müller D, Jokiranta TS. Monkey malaria in a European traveler returning from Malaysia. Emerg Infect Dis. 2008;14:1434–6.
- Krotoski WA, Collins WE. Failure to detect hypnozoites in hepatic tissue containing exoerythrocytic schizonts of Plasmodium knowlesi. Am J Trop Med Hyg. 1982;31:854–6.
- A single parasite gene determines strain-specific protective immunity against malaria: the role of the merozoite surface protein I. Int J Parasitol. 2010;40:951–61.
- Figure. Phylogenetic trees based on nucleotide sequences of small subunit rRNA of Plasmodium knowlesi isolates from Peninsular Malaysia (Pkpah-1, Pkprk-1, KAL-1) and surrounding regions (denoted by GenBank accession nos.). The tree...
Please use the form below to submit correspondence to the authors or contact them at the following address:
Yee Ling Lau, Department of Parasitology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: August 15, 2011
- Page last updated: August 15, 2011
- Page last reviewed: August 15, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)